Archives

by in
Entry Author Date Location
Quanterix Garners New Funding Round 01/05/12 Boston
HubSpot Buys OneForty, Cambridge Diagnostics Startups Nab Funding, Hopper Closes $8M, & More Boston-Area Deals News 08/24/11 Boston
Quanterix Finds $6M 08/23/11 Boston
Quanterix Receives $5,999,998 New Round 08/19/11 Boston
Quanterix Partners With Novartis, Athenahealth and Microsoft Sync Up, Vertex Nails Clinical Trial, & More Boston-Area Life Sciences News 02/25/11 Boston
Quanterix, Novartis Test Out Super-Sensitive Diagnostic Tool for Neuro Disorder 02/22/11 Boston
Quanterix Adds Former Millipore CEO as Chair 12/01/10 Boston
Akrivis Sets Out to Improve Diagnostics and Therapies with Northeastern U. Tech 11/23/10 Boston
Ouch for Arch: VC Bob Nelsen Says Ikaria Will March On After Withdrawing Big IPO 11/12/10 Seattle
Big Fish Help Out the Smaller Fish in the Life Sciences Pond 11/09/10 National
Shots from the Front Row of Boston’s War on Cancer Event 10/22/10 Boston
Alkermes Drug Approved for Opioid Addiction, Genzyme Faces Shareholder Lawsuits, NinePoint Gets $33M, & More Boston-Area Life Sciences News 10/15/10 Boston
Mike Huckman, Former CNBC Reporting Ace, Joins Stellar Lineup at Boston’s War on Cancer 10/14/10 Boston
Where Will the Next Gleevec Come From? Xconomy Forum Looks At the Edge of Cancer R&D 10/05/10 Boston
What Is Boston Doing for the War on Cancer? Find Out at Xconomy Forum on October 20 08/25/10 Boston
FDA Approves Genzyme Pompe Drug, Vertex Hepatitis C Drug Trial Succeeds, Thermo Fisher Acquires Fermentas, & More Boston-Area Life Sciences News 05/28/10 Boston
Quanterix Uses Fiber Optics to Find Cancer Protein, Nears New Funding Round 05/27/10 Boston
IkaSystems Raises $120M, New CEOs of Qteros, Bind, and Quanterix Dish the Dirt, & More Boston-Area Life Sciences News 01/20/10 Boston
Quanterix CEO Sets Sight on Early Detection of Cancer, Neurological Diseases in the Blood 01/19/10 Boston
New VC in Boston: Arch Venture Partners Opens Small Office With Eye Toward Basic Science, Multidisciplinary Collaborations 09/21/09 Boston
Federal Judge Rules in Biogen Idec’s Favor, Sepracor Agrees to $2.8B Buyout, FDA Panel Endorses Gloucester Pharma Drug, & More Boston-Area Life Sciences News 09/11/09 Boston
Quanterix Taps New CEO 09/02/09 Boston
How to Build a Billion-Dollar Company (And Keep An Academic Day Job), According to David Walt 08/31/09 National
Seventh Sense Biosystems Developing Tech Akin to Check-Engine Light for the Body 06/05/09 Boston
New England’s Top Third-Quarter Venture Deals—the List 10/20/08 Boston
New Biotech Biz Models (and the Tested Bob Langer-Terry McGuire Approach) Emerge at Xconomy Forum 09/25/08 Boston
How to Build a Life Sciences Company: Xconomy Forum Tomorrow 09/22/08 Boston
Pharmas Flock to Sermo, Biogen Idec Takes Another Tack with MS, $400M More for the Broad Institute, & More Life Sciences News 09/04/08 Boston
Investors Radio in $32M for Vanu, JumpTap’s Bank Balance Hops up by $26M, Quanterix Pinpoints $15M, & More Deals News 09/02/08 Boston
Quanterix Developing Instrument to Detect Cancer at its Earliest, Most Curable Stages 08/29/08 Boston
Page 1 of 2 next page »

Xconomy Events Across the Network

XSITE 2013: Boston’s Tech Revival

Boston · 6/19/13
9:00 am

More Xconomy Events

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  4. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos
  5. Digital Lumens, Finding Its Identity, Brings Cost & Energy Savings to Light

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.